Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
J Anat ; 232(2): 263-269, 2018 02.
Article in English | MEDLINE | ID: mdl-29148044

ABSTRACT

Laterally bent dorsal fins are rarely observed in free-ranging populations of cetaceans, contrary to captivity, where most killer whale Orcinus orca adult males have laterally collapsed fins. This topic has been poorly explored, and data/information on its occurrence and possible causes are limited. The present study: (i) undertakes a review of the available information on bent dorsal fins in free-ranging cetaceans, and updates it with new records, (ii) reports on the proportion of bent fins in different study populations, and (iii) discusses possible causes. An empirical approach based on bibliographic research and compilation of 52 new records collected worldwide resulted in a total of 17 species of cetaceans displaying bent dorsal fins. The species with the highest number of records (64%) and from most locations was O. orca. On average, individuals with bent dorsal fins represent < 1% of their populations, with the exception of false killer whales Pseudorca crassidens and O. orca. While line injuries associated with fisheries interactions may be the main cause for P. crassidens, and the vulnerability to health issues caused by the evolutionary enlargement of the fin may be the cause for O. orca adult males, factors contributing to this abnormality for other species are still unclear. The occurrence of bent dorsals could be influenced by a set of variables rather than by a single factor but, irrespective of the cause, it is suggested that it does not directly affect the animals' survivorship. While still rare in nature, this incident is more common (at least 101 known cases) and widespread (geographically and in species diversity) than hypothesized, and is not confined only to animals in captive environments. Investigation into the occurrence of bent fins may be an interesting avenue of research.


Subject(s)
Animal Fins/abnormalities , Cetacea/abnormalities , Animals , Incidence
2.
Cytokine ; 89: 229-234, 2017 01.
Article in English | MEDLINE | ID: mdl-26817396

ABSTRACT

Endometriosis is a gynecological benign chronic disease defined as the growth of endometrial glands and stroma in extra-uterine sites, most commonly implanted over visceral and peritoneal surfaces within the female pelvis causing inflammatory lesions. It affects around 10% of the female population and is often accompanied by chronic pelvic pain, adhesion formation and infertility. Therefore, endometriosis could be considered a "social disease", since it affects the quality of life, reproductivity and also has a socio-economic impact. The expression of cell cycle and inflammatory proteins is modified in the endometriotic tissues. Immunostaining of glandular and stromal cells in endometrial biopsies obtained from patients with endometriosis compared with those of healthy control demonstrated that endometriotic tissues have lower levels of p27kip1 protein. Endometriosis endometrial cells cultures have also lower levels of p27kip1 compared to health endometrial cells cultures and restore the cell cycle balance when transduced with an adenoviral vector carring the p27kip1 coding gene (Adp27EGFP). The low levels of p27kip1 are related to the S phase in the cell cycle, whereas higher levels lead to a G1 cell cycle arrest. The inflammatory cytokine IL-1ß was recently identified as another key protein in the endometriosis proliferation. This cytokine has elevated levels during the proliferative and secretory phases of the menstrual cycle. In endometriosis endometrial cells cultures the IL-1ß stimulates the production of IL-6 and IL-8, increasing the cell proliferation and reducing the apoptosis and Bax expression in these cells. According to these remarks, this work aims to evaluate the inflammatory effects in vitro, but more next to what happens in a woman's body, associating endometrial cells with stem cells, thus mimicking the endometrial microenvironment, with gene therapy using Adp27, notoriously known as controller cell cycle, apoptosis and potent modulator of VEGF expression.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p27/biosynthesis , Endometriosis/metabolism , Endometrium/metabolism , G1 Phase Cell Cycle Checkpoints , Interleukin-1beta/metabolism , S Phase , Stem Cell Niche , Adult , Coculture Techniques , Cyclin-Dependent Kinase Inhibitor p27/genetics , Endometriosis/genetics , Endometriosis/therapy , Endometrium/pathology , Female , Humans , Interleukin-1beta/genetics , Transduction, Genetic
3.
Science ; 292(5514): 107-10, 2001 Apr 06.
Article in English | MEDLINE | ID: mdl-11292875

ABSTRACT

The Drosophila melanogaster gene insulin-like receptor (InR) is homologous to mammalian insulin receptors as well as to Caenorhabditis elegans daf-2, a signal transducer regulating worm dauer formation and adult longevity. We describe a heteroallelic, hypomorphic genotype of mutant InR, which yields dwarf females with up to an 85% extension of adult longevity and dwarf males with reduced late age-specific mortality. Treatment of the long-lived InR dwarfs with a juvenile hormone analog restores life expectancy toward that of wild-type controls. We conclude that juvenile hormone deficiency, which results from InR signal pathway mutation, is sufficient to extend life-span, and that in flies, insulin-like ligands nonautonomously mediate aging through retardation of growth or activation of specific endocrine tissue.


Subject(s)
Aging/physiology , Carrier Proteins/genetics , Carrier Proteins/physiology , Corpora Allata/metabolism , Drosophila Proteins , Drosophila melanogaster/physiology , Longevity/physiology , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/physiology , Receptor Protein-Tyrosine Kinases , Alleles , Animals , Drosophila melanogaster/genetics , Female , Fertility , Genes, Insect , Genotype , Insulin/pharmacology , Juvenile Hormones/metabolism , Male , Methoprene/pharmacology , Mutation , Receptor, Insulin/genetics , Receptor, Insulin/physiology , Reproduction , Signal Transduction , Superoxide Dismutase/metabolism , Triglycerides/metabolism , Vitellogenesis/drug effects
4.
J Pediatr ; 135(3): 345-50, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10484801

ABSTRACT

OBJECTIVES: To test the hypothesis that a single dose of dexamethasone given soon after delivery to infants <28 weeks' gestation leads to improved cardiopulmonary adaptation in the first week and lowers the risk of significant intraventricular hemorrhage. METHODS: In a prospective, blinded, placebo-controlled study, we randomly assigned 70 infants <28 weeks' gestation who were born in the hospital to receive dexamethasone (0.2 mg/kg) (n = 37) or normal saline solution (n = 33) within 2 hours of delivery. After an interim analysis showed that the incidence of intraventricular hemorrhage was much lower than expected, enrollment was stopped and we limited our analysis to a comparison of ventilator settings, blood pressure, and pressor use during the first 7 days. RESULTS: Clinical characteristics of the groups were comparable at study entry. Ventilator weaning occurred more rapidly in the patients who received dexamethasone: their intermittent mandatory ventilation rate was significantly lower on days 1 through 6, and their peak inspiratory pressure was lower on days 3 through 7 compared with the control group. Mean blood pressures were higher in the dexamethasone group within 12 hours and remained higher through day 5, but the use of pressors was not different. Fewer infants in the dexamethasone group received indomethacin to treat a patent ductus arteriosus (22% vs 47%, P <.03). CONCLUSION: Dexamethasone given within 2 hours of delivery to preterm infants <28 weeks' gestation resulted in lower ventilator settings and higher mean blood pressures during the first 7 days. Fewer infants required indomethacin to treat a patent ductus arteriosus.


Subject(s)
Adaptation, Physiological/drug effects , Anti-Inflammatory Agents/therapeutic use , Cardiovascular Physiological Phenomena/drug effects , Cerebral Hemorrhage/prevention & control , Cerebral Ventricles , Dexamethasone/therapeutic use , Infant, Premature, Diseases/prevention & control , Respiratory Physiological Phenomena/drug effects , Anti-Inflammatory Agents/pharmacology , Blood Pressure/drug effects , Cause of Death , Cerebral Hemorrhage/mortality , Dexamethasone/pharmacology , Female , Humans , Infant, Newborn , Infant, Premature, Diseases/mortality , Male , Postnatal Care/methods , Prospective Studies , Single-Blind Method , Time Factors
7.
J Pediatr ; 124(2): 294-301, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8301442

ABSTRACT

The effect of a 50% increment or decrement in the recommended 5 ml/kg dose of a commercially available surfactant (Exosurf Neonatal) on the alveolar-arterial oxygen gradient was investigated in a multicenter, double-blind, placebo-controlled rescue trial conducted at 15 hospitals in the United States. Two doses of three different volumes (2.5, 5.0, and 7.5 ml/kg) were compared with two 5.0 ml/kg doses of air in 281 infants weighing > or = 1250 gm who had respiratory distress syndrome requiring mechanical ventilation and an arterial/alveolar oxygen ratio < 0.22. The first dose was given between 2 and 24 hours of age, and the second dose was given 12 hours later to all infants who still required mechanical ventilation. Infants were stratified at entry by gender and the magnitude of the arterial/alveolar oxygen ratio. The air placebo arm of the study was terminated early when reductions in mortality rates were proved in another rescue trial of this surfactant in infants with the same birth weights. For the first 48 hours, administration of a 2.5 ml/kg dose of surfactant provided less improvement in the alveolar-arterial oxygen gradient than doses of 5.0 and 7.5 ml/kg, which were equivalent. Similar results were observed in mean airway pressure (p < 0.05). There were no significant differences among the three dosage groups in mortality rate, air leak, bronchopulmonary dysplasia, and other complications of prematurity. There were no pulmonary hemorrhages in any group. Reflux of surfactant occurred more frequently in the 5.0 and 7.5 ml/kg groups. These results indicate that more sustained improvements in oxygenation are provided, with equal safety, by the standard two 5.0 ml/kg rescue doses of this surfactant than by the 2.5 ml/kg dose. No further benefit is gained from two larger doses given 12 hours apart.


Subject(s)
1,2-Dipalmitoylphosphatidylcholine/analogs & derivatives , Infant, Premature , Pulmonary Gas Exchange/drug effects , Pulmonary Surfactants/administration & dosage , Respiratory Distress Syndrome, Newborn/drug therapy , 1,2-Dipalmitoylphosphatidylcholine/administration & dosage , 1,2-Dipalmitoylphosphatidylcholine/pharmacology , 1,2-Dipalmitoylphosphatidylcholine/therapeutic use , Birth Weight , Blood Pressure , Double-Blind Method , Female , Humans , Infant, Low Birth Weight/physiology , Infant, Newborn , Infant, Premature/physiology , Male , Oxygen/blood , Oxygen Inhalation Therapy , Pulmonary Surfactants/pharmacology , Pulmonary Surfactants/therapeutic use , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/mortality , Respiratory Distress Syndrome, Newborn/physiopathology
8.
Dev Pharmacol Ther ; 18(1-2): 65-70, 1992.
Article in English | MEDLINE | ID: mdl-1483364

ABSTRACT

We examined the effect of the calcium channel blocker nimodipine on postischemic hypoperfusion in the newborn piglet brain. A severe pneumothorax (SP) was induced by injecting air into the right thorax until the mean arterial blood pressure fell to 25% of baseline and was maintained for 4 min. Blood flow was immediately reduced 70-90% from baseline in each brain region during SP. In untreated animals postischemic hypoperfusion existed at 60 min, following recovery from SP with regional brain blood flow reduced 20-30% from baseline. Nimodipine infusion after SP prevented postischemic hypoperfusion in all brain regions and increased blood flows by as much as 40% above baseline in midbrain and brainstem structures. Nimodipine infusion began after severe brain ischemia prevented postischemic hypoperfusion and enhanced brain blood flow in this model.


Subject(s)
Brain Ischemia/drug therapy , Nimodipine/therapeutic use , Animals , Animals, Newborn , Brain/blood supply , Hydrogen-Ion Concentration , Pneumothorax , Swine
9.
Arch Dis Child ; 66(1 Spec No): 48-51, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1996892

ABSTRACT

To test the hypothesis that acute hypotension resulting from pneumothorax would be associated with severe brain injury (grade 3 or 4 intraventricular haemorrhage), 67 very low birthweight (VLBW) infants of 32 weeks' gestation or less with respiratory distress syndrome and pneumothorax were studied. Thirty six had pneumothorax associated with systemic hypotension and 31 had pneumothorax with normal blood pressure. The groups were similar in gestational age and severity of their respiratory distress syndrome. Thirty two of 36 of infants with pneumothorax associated with hypotension (89%) had grade 3 or 4 intraventricular haemorrhage. This percentage was significantly greater than the percentage for infants with pneumothorax and normal blood pressure (three of 31, 10%). The risk ratio for grade 3 or 4 intraventricular haemorrhage for infants with pneumothorax associated with hypotension was 9.8 compared with neonates with pneumothorax and normal blood pressure. These observations are consistent with the hypothesis that systemic hypotension and cerebral hypoperfusion are important factors leading to intraventricular haemorrhage in VLBW infants.


Subject(s)
Cerebral Hemorrhage/etiology , Hypotension/etiology , Infant, Low Birth Weight , Pneumothorax/complications , Female , Humans , Incidence , Infant, Newborn , Male , Respiratory Distress Syndrome, Newborn/complications , Retrospective Studies
12.
N Engl J Med ; 318(11): 677-83, 1988 Mar 17.
Article in English | MEDLINE | ID: mdl-3344019

ABSTRACT

The federal regulations now in effect governing the treatment of severely handicapped infants--the so-called Baby Doe regulations--are based on the 1984 amendments to the Child Abuse Prevention and Treatment Act; these regulations require that, except under certain specified conditions, all newborns receive maximal life-prolonging treatment. We sent questionnaires to the 1007 members of the Perinatal Pediatrics Section of the American Academy of Pediatrics to determine their views on the Baby Doe regulations and on whether the regulations had affected their practices; 494 of the members (49 percent) responded. Of the respondents, 76 percent believed that the current regulations were not necessary to protect the rights of handicapped infants; 66 percent believed that the regulations interfered with parents' right to determine what course of action was in the best interest of their children; and 60 percent believed that the regulations did not allow adequate consideration of infants' suffering. In responding to the three hypothetical cases of severely handicapped newborns, up to 32 percent of the respondents said that maximal life-prolonging treatment was not in the best interests of the infants described but that the Baby Doe regulations required such treatment. The responding neonatologists' concerns about the current Baby Doe regulations were similar to those expressed by the United States Supreme Court in rejecting an earlier set of Baby Doe regulations. This similarity suggests that the current Baby Doe regulations should be reevaluated.


Subject(s)
Abnormalities, Multiple , Child Abuse/legislation & jurisprudence , Child Advocacy/legislation & jurisprudence , Neonatology , Attitude of Health Personnel , Euthanasia, Passive , Humans , Infant, Newborn , Parents , Surveys and Questionnaires , United States
16.
Pediatr Pathol ; 6(2-3): 325-33, 1986.
Article in English | MEDLINE | ID: mdl-3822943

ABSTRACT

Meconium pleuritis developed in a neonate with a perforation of the sigmoid colon, through a diaphragmatic defect. The meconium released in the abdomen communicated with the right pleural space. The association of these defects is unusual, and the cytologic diagnosis of meconium pleuritis has not been previously reported.


Subject(s)
Colonic Diseases/congenital , Hernias, Diaphragmatic, Congenital , Intestinal Perforation/congenital , Meconium , Pleurisy/etiology , Colonic Diseases/pathology , Cytodiagnosis , Hernia, Diaphragmatic/pathology , Humans , Infant, Newborn , Intestinal Perforation/pathology , Male , Peritonitis/etiology , Peritonitis/pathology , Pleurisy/diagnostic imaging , Pleurisy/pathology , Radiography
17.
Am J Dis Child ; 137(12): 1179-80, 1983 Dec.
Article in English | MEDLINE | ID: mdl-6416060

ABSTRACT

Four ill preterm infants each had a severely dilated gallbladder that was detected as a right-upper-quadrant abdominal mass. In each infant, the diagnosis was suspected on physical examination and confirmed by ultrasound study. One extremely premature infant with respiratory distress syndrome died, and at autopsy, the gallbladder and biliary tree showed no abnormalities, except for severe gallbladder distention. In the other three infants, distention of the gallbladder resolved spontaneously.


Subject(s)
Gallbladder/physiopathology , Infant, Premature, Diseases/physiopathology , Adult , Diseases in Twins , Female , Humans , Infant, Newborn , Male , Parenteral Nutrition, Total , Respiratory Distress Syndrome, Newborn/physiopathology , Ultrasonography
18.
Am J Dis Child ; 137(9): 842-5, 1983 Sep.
Article in English | MEDLINE | ID: mdl-6193707

ABSTRACT

Twins had congenital hyperthyroidism and delayed cerebral development manifested as ventriculomegaly, increased space in the interhemispheric fissure, and an exaggerated gyral pattern on cranial computed tomographic scans. At 3 1/2 years of age, both children had delayed development. Fetal and neonatal hyperthyroidism may interfere with normal brain growth and maturation with both neuranatomic and developmental sequelae.


Subject(s)
Brain/growth & development , Developmental Disabilities/etiology , Diseases in Twins , Hyperthyroidism/congenital , Adult , Brain/diagnostic imaging , Cerebral Ventricles/pathology , Cerebral Ventriculography , Child, Preschool , Developmental Disabilities/diagnosis , Female , Follow-Up Studies , Humans , Hyperthyroidism/complications , Infant , Infant, Newborn , Time Factors , Tomography, X-Ray Computed
19.
Prostaglandins Leukot Med ; 10(4): 423-31, 1983 Apr.
Article in English | MEDLINE | ID: mdl-6574525

ABSTRACT

In order to determine if prostaglandin values correlate with gestational age, birth weight, postnatal age, or respiratory distress syndrome (RDS), we determined plasma prostaglandin F2 alpha (PGF2 alpha) and prostaglandin E2 (PGE2) by specific radioimmunoassay in 34 samples from 27 preterm infants. Neither prostaglandin correlated with gestational age or with birth weight. PGF2 alpha decreased (p less than 0.3) with postnatal age. Values for PGF2 alpha and PGE2 in each sample varied together (p less than .01) but only PGF2 alpha increased (p less than .09) in infants with RDS. The highest PGF2 alpha values occurred in infants with severe RDS, including four infants with patent ductus arteriosus (PDA). In contrast, plasma PGE2 was not elevated in infants with RDS or PDA.


Subject(s)
Ductus Arteriosus, Patent/blood , Infant, Premature , Prostaglandins E/blood , Prostaglandins F/blood , Respiratory Distress Syndrome, Newborn/blood , Age Factors , Birth Weight , Dinoprost , Dinoprostone , Gestational Age , Humans , Infant, Newborn
SELECTION OF CITATIONS
SEARCH DETAIL
...